X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

ANNALS OF THE RHEUMATIC DISEASES

期刊標題檢索 ANN RHEUM DIS 最新評論: What if it changes back to "Awaiting AE Assignment" after "Awaiting ... (2024-03-09)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[ANNALS OF THE RHEUMATIC DISEASES]您好,您是該頁面的第 45368 位訪客。

期刊簡介
期刊名稱ANNALS OF THE RHEUMATIC DISEASES ANNALS OF THE RHEUMATIC DISEASES
LetPub Score
9.6
50 ratings
Rate

Reputation
9.9

Influence
9.3

Speed
9.7

期刊簡稱ANN RHEUM DIS
ISSN0003-4967
E-ISSN1468-2060
h-index212
CiteScore
CiteScoreSJRSNIPCiteScore Rank
35.006.1384.626
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Rheumatology
Q11 / 73
Category: Medicine
Subcategory: General Biochemistry, Genetics and Molecular Biology
Q14 / 221
Category: Medicine
Subcategory: Immunology and Allergy
Q15 / 233
Category: Medicine
Subcategory: Immunology
Q16 / 236

自引率 (2023-2024)7.40%自引率趨勢
掲載範囲
Annals of the Rheumatic Diseases (ARD) is an international peer review journal committed to promoting the highest standards of scientific exchange and education. It covers all aspects of rheumatology, which includes the spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research. Concise scientific communication is encouraged and peer reviewed proceedings of international meetings are featured. Educational papers include state of the art reviews, "how to" articles and educational cases that focus on problems faced in clinical practice. The journal was first published in 1939 and has an authorative global Editorial Board and a growing international readership.
官方網站http://ard.bmj.com/
在線稿件提交https://mc.manuscriptcentral.com/ard
開放訪問No
出版商BMJ Publishing Group
主題領域医学
出版國/地區ENGLAND
發行頻率月刊
創刊年1939
每年文章數148每年文章數趨勢
黃金OA百分比45.23%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
RHEUMATOLOGYSCIEQ12/57
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0003-4967%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 1.4 Month(s)
競爭力 *來自作者的數據: About 25%
參考鏈接
相關期刊 【ANNALS OF THE RHEUMATIC DISEASES】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Nature Reviews RheumatologyH-index: 113

    CiteScore: 29.90
    Osteoarthritis and CartilageH-index: 138

    CiteScore: 11.70
    CURRENT OPINION IN RHEUMATOLOGYH-index: 102

    CiteScore: 9.70
    RHEUMATOLOGYH-index: 156

    CiteScore: 9.40
    SEMINARS IN ARTHRITIS AND RHEUMATISMH-index: 102

    CiteScore: 9.20
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGYH-index: 89

    CiteScore: 9.40
    JOINT BONE SPINEH-index: 71

    CiteScore: 4.50
    JOURNAL OF RHEUMATOLOGYH-index: 165

    CiteScore: 6.50
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGYH-index: 87

    CiteScore: 6.10
    RHEUMATOLOGY INTERNATIONALH-index: 66

    CiteScore: 7.30
    學科內最受檢索的期刊 頁面查看次數
    BMC MUSCULOSKELETAL DISORDERS81692
    RHEUMATOLOGY57704
    Osteoarthritis and Cartilage53945
    CLINICAL RHEUMATOLOGY41487
    JOURNAL OF RHEUMATOLOGY36359
    LUPUS32459
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY28475
    JOINT BONE SPINE27842
    Nature Reviews Rheumatology25228
    SEMINARS IN ARTHRITIS AND RHEUMATISM25106
  •  

    ANNALS OF THE RHEUMATIC DISEASES ANNALS OF THE RHEUMATIC DISEASES
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    下一頁    末頁  (頁
/2)
  [ANNALS OF THE RHEUMATIC DISEASES] 的評論撰寫評論
作者: 苍风乐岚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-09 18:40:24 評論於
What if it changes back to "Awaiting AE Assignment" after "Awaiting Second Opinion Comments"?
(0) 讚! | 苍风乐岚

作者: Moon


領域: 生物学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2022-09-05 15:51:29 評論於
Authoritative magazine
Very difficult
High requirements for innovation and clinical significance
(1) 讚! | Moon

作者: 莎乐美爱德华


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-24 23:26:10 評論於
About 3-5 days
(0) 讚! | 莎乐美爱德华

作者: 莎乐美爱德华


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-24 10:00:56 評論於
If sent for external review later, it will be peer review in progress
(0) 讚! | 莎乐美爱德华

作者: 其英超级甜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-02-20 23:37:10 評論於
How long after this status appeared did it show as under review?
(0) 讚! | 其英超级甜

作者: 蒙德雪蕊


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-01-19 16:22:36 評論於
What is proof?
(0) 讚! | 蒙德雪蕊

作者: 莎乐美爱德华


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-07 10:13:39 評論於
My post on "Awaiting Second Opinion Comments" was under review, hoping for a good outcome. I was anxious when searching for answers before, thinking it was hopeless. But since no one had replied before, I decided to leave a comment here
(0) 讚! | 莎乐美爱德华

作者: 昂杰来了


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-05 16:33:57 評論於
How long has a great god, awaiting second opinion comments, lasted?
(0) 讚! | 昂杰来了

作者: 昂杰来了


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-01 16:29:13 評論於
Bro, what states have you been through?
(0) 讚! | 昂杰来了

作者: 昂杰来了


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-11-27 23:14:26 評論於
Hey man, what happened to you later?
(0) 讚! | 昂杰来了

作者: 香灵少爷


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-09-17 18:12:09 評論於
Review speed: 1.0 | Submission hit rate: 5.0
Experience sharing: I submitted my paper a little after ten o'clock in the morning on the first day, and I received a rejection letter the next day at nine o'clock in the morning, desk reject. This is my first time submitting to a SCI journal, really don't be too happy!!!
(0) 讚! | 香灵少爷

作者: 是你的友竹呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-08-09 22:27:36 評論於
What was the situation like afterwards?
(0) 讚! | 是你的友竹呀

作者: Myrna Milton


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-07-07 13:13:44 評論於
Oh great one, please accept my worship
(0) 讚! | Myrna Milton

作者: 筑阳冷玉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-01-17 15:51:27 評論於
Review speed: 1.0 | Submission acceptance rate: 95.0
Experience sharing: Have published two communication articles
(0) 讚! | 筑阳冷玉

作者: Eartha Norris


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-07-09 23:09:15 評論於
Review Speed: 1.0
Research Focus: Immune Experience Sharing
Submitted a communication, received a reply within a week, accepted without revisions, waiting for proof, very fast speed
(0) 讚! | Eartha Norris

作者: 小志鹏吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-03-21 23:17:40 評論於
Does this magazine accept review articles? How fast is the review process?
(0) 讚! | 小志鹏吖

作者: Rosemary Faraday


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-11-27 18:53:25 評論於
Have you submitted, great one?
150****7505 (No pseudonym)   Posted on 2018-01-22:
I'd like to ask all you experts, does the journal Case Report accept submissions?
(0) 讚! | Rosemary Faraday

作者: Oliver Jerry


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-10-25 08:31:57 評論於
I don't know
(0) 讚! | Oliver Jerry

作者: 凯伦福克斯


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-09-04 18:21:35 評論於
The review speed, online speed, and founding speed are all very fast, with the first review generally completed within a month. It does not choose OA, does not require page charges, and does not charge for color images. The journal is very rigorous and demands high innovation
(0) 讚! | 凯伦福克斯

作者: 凯伦福克斯


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-02-01 14:06:28 評論於
I have submitted three papers so far. The first two were rejected within three days without external review. The third one was sent for external review in four days, which took exactly one month. With feedback from three reviewers recommending major revisions, I have now resubmitted it. As the new year begins, I hope for a positive outcome
(0) 讚! | 凯伦福克斯

作者: 凯伦福克斯


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-01-29 09:33:57 評論於
I have submitted three articles so far. The first two were rejected in about 3 days without external review. The third one was sent for external review in 4 days. It took exactly one month, with three reviewers suggesting major revisions. I have now resubmitted the article and hope for a positive outcome in the new year
(0) 讚! | 凯伦福克斯

作者: Erica Locke


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-01-22 08:40:48 評論於
Can you tell me if this journal accepts case reports?
(0) 讚! | Erica Locke

作者: 东海兴海


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-04-11 13:56:42 評論於
Multiple Submissions
(0) 讚! | 东海兴海

作者: 风见初阳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-02-21 09:01:42 評論於
What is the status of your article next?
(0) 讚! | 风见初阳

作者: 松风雨凝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-12-14 11:47:15 評論於
Review Speed: 1.0 | Submission Hit Rate: 25.0
Experience sharing: The official journal of the European League Against Rheumatism, ranks first in the field, covering all aspects of rheumatology, including musculoskeletal, arthritis, and connective tissue diseases, and related basic, clinical, and translational research. 
Acceptance Rate: 12% (original research articles)
Publication Speed: Submission to initial decision: average 17 days (original research articles)
Acceptance to publication: average 13 days (online publication
(0) 讚! | 松风雨凝

首頁    上一頁    1    2    下一頁    末頁  (頁
/2)

開始撰寫 [ANNALS OF THE RHEUMATIC DISEASES] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*